Polypharmacy in patients with advanced cancer and the role of medication discontinuation (Q38543405)

4 September 2017

1 reference

title

Polypharmacy in patients with advanced cancer and the role of medication discontinuation (English)

1 reference

4 September 2017

1

0 references

David C. Currow

series ordinal

4

0 references

Amy P. Abernethy

series ordinal

5

object named as

Amy P Abernethy

1 reference

4 September 2017

Michael J McNeil

2

1 reference

4 September 2017

Arif H Kamal

series ordinal

3

1 reference

4 September 2017

publication date

1 July 2015

1 reference

Lancet Oncology Commission

4 September 2017

published in

1 reference

4 September 2017

volume

16

1 reference

4 September 2017

issue

7

1 reference

4 September 2017

page(s)

e333-41

1 reference

Communicating information about drug safety

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Risk factors for adverse drug events among nursing home residents

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

The impact of number of drugs prescribed on the risk of potentially inappropriate medication among outpatient older adults with chronic diseases

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Preventive medication use among persons with limited life expectancy.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Polypharmacy in elderly patients with cancer: clinical implications and management.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Polypharmacy in elderly patients

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Polypharmacy in the elderly: a literature review

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Managing medications in clinically complex elders: "There's got to be a happy medium".

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Managing comorbidities in patients at the end of life

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Geriatric Oncology and Palliative Medicine

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Prevalence and factors associated with polypharmacy in older people with cancer

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

The treatment of co-morbidities in older patients with metastatic cancer

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Use of unnecessary medications by patients with advanced cancer: cross-sectional survey

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Polypharmacy in patients with advanced cancer and pain: a European cross-sectional study of 2282 patients

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Medication problems in older, newly diagnosed cancer patients in Canada: How common are they? A prospective pilot study

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Variation in medication use in cancer patients at the end of life: a cross-sectional analysis.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Patients with advanced lung cancer: is there scope to discontinue inappropriate medication?

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Prescribing in palliative care as death approaches.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Commonly prescribed medications in a population of hospice patients

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Polypharmacy and drug omissions across hospices in Northern Ireland

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Pharmacological management of co-morbid conditions at the end of life: is less more?

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Drugs in palliative care: results from a representative survey in Germany

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Prescribing for comorbid disease in a palliative population: focus on the use of lipid-lowering medications.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Pharmacotherapy at the end-of-life

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Changes in anticholinergic load from regular prescribed medications in palliative care as death approaches

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Potential drug interactions and duplicate prescriptions among ambulatory cancer patients: a prevalence study using an advanced screening method

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Consensus validation of the FORTA (Fit fOR The Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Quality indicators for medication use in vulnerable elders

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Discontinuation of statins in routine care settings

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Impact of a geriatric nursing home palliative care service on unnecessary medication prescribing

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Statin prescribing patterns in a cohort of cancer patients with poor prognosis

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Statins in the last six months of life: a recognizable, life-limiting condition does not decrease their use

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Appropriate discontinuation of medications at the end of life: a need to establish consensus criteria

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Futile medication use in terminally ill cancer patients

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Developing the evidence base for palliative care: formation of the Palliative Care Research Cooperative and its first trial

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Rational prescribing for patients with a reduced life expectancy

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Reconsidering medication appropriateness for patients late in life

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(15)50080-7

7 January 2021

10.1016/S1470-2045(15)00080-7

Identifiers

DOI

1 reference

4 September 2017

1 reference